VNTH news out
They are gearing up. Where are we?
This is fairly serious imho. The Alliance Boots connection appears alive in some form. I'd put the Alliance Boots guy in my group if there are stakes involving that group still, in particular.
SD
REDWOOD CITY, Calif.--(BUSINESS WIRE)--September 22, 2014--
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company") today announced the appointment of Tony van Bijleveld as an independent member of the Board of Directors of Vantage Health, Inc.
Mr. van Bijleveld is currently General Manager with leading drug manufacturer Patheon/DPX. Patheon is a leading global provider of contract drug development and manufacturing services. Their integrated network consists of seven development centers of excellence and thirteen manufacturing facilities across North America, Asia and Europe. Patheon provides pharmaceutical and biotechnology companies with direct access to the expertise, quality and full range of solid and sterile dosage forms to bring drug candidates from preclinical stages through production, and launch products anywhere in the world.
Up until this past spring, Mr. van Bijleveld was the General Manager of Europe for Alliance Boots which is 45% owned by Walgreens. In this capacity he was responsible for European country operations and logistics. Alliance Boots, with a presence in more than 25 countries and over 108,000 employees is a leading international, pharmacy-led health and beauty group delivering a range of products and services to customers. Their focus is on pharmacy-led retailing and pharmaceutical wholesaling and distribution. Alliance Boots operate more than 3,150 health & beauty retail stores, of which just over 3,050 have a pharmacy.
Mr. van Bijleveld has been instrumental in the development of top-performing global businesses in diagnostics, pharmaceuticals and biotechnology industries in over 30 countries, reflecting his experience in general management, marketing and sales management, acquisitions, operational excellence, and licensing and business development.
Over the past 30 years he has served in a variety of senior executive capacities in the pharmaceutical and biotech industry including: Managing Director of United Drug PLC, President/General Manager Russia for Schering Plough/MSD, SVP of Organon Biosciences, and Managing Director of KCL Foundation Labs. A native Australian, Mr. van Bijleveld has earned advanced degrees in Pharmacology, Biochemistry, Engineering and an MBA, from colleges in Australia, Holland and Candean.
More news will be forthcoming this week as the Company expands and reconstitutes its Board.
